JON SHIRAZI: Open Payments
NPI 1982447173 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 43 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $375 |
| Lilly USA, LLC | 3 | $155 |
| HARMONY BIOSCIENCES LLC | 5 | $122 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $84 |
| Novo Nordisk Inc | 4 | $74 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| AERIN MEDICAL INC. | 1 | $24 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Sunosi, ZEPBOUND, WAKIX, LUMRYZ, TRELEGY ELLIPTA, Wegovy, BREZTRI, VIVAER STYLUS.
Industry payments across MD — which companies pay providers there.
